Cite

HARVARD Citation

    Terova, O. et al. (2018). Overcoming downstream purification challenges for viral vector manufacturing: enabling advancement of gene therapies in the clinic. Cell & gene therapy insights. 4 (2), p. . [Online]. 
  
Back to record